A Randomized, Double-Blind, Four-Period, Crossover Study to Evaluate the Cardiovascular Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Subjects
Latest Information Update: 06 Jul 2020
At a glance
- Drugs Lasmiditan (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 26 May 2020 Results assessing pharmacokinetics, safety and tolerability of lasmiditan in elderly and young healthy subjects from two clinical studies: NCT03286218 and NCT03310411 presented at the 6th Congress of the European Academy of Neurology
- 19 Jan 2018 Status changed from recruiting to completed.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.